Identification Somatic Variants FOXO3A and FOXK2 in Neuroblastoma Patients that May Affect Doxorubicin and Platin Chemoterapy

dc.contributorUniversidade de São Paulo (USP)
dc.contributorPediat Hematol Oncol Dept
dc.contributorLab Med Invest LIM 36
dc.contributorAC Camargo Canc Ctr
dc.contributorDept Genet & Evolutionary Biol
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorHIAE
dc.contributorFundacao Prosangue Hemoctr Sao Paulo Sao Paulo
dc.date.accessioned2019-10-04T12:42:42Z
dc.date.accessioned2022-12-19T18:15:38Z
dc.date.available2019-10-04T12:42:42Z
dc.date.available2022-12-19T18:15:38Z
dc.date.created2019-10-04T12:42:42Z
dc.date.issued2018-11-01
dc.identifierPediatric Blood & Cancer. Hoboken: Wiley, v. 65, p. S269-S269, 2018.
dc.identifier1545-5009
dc.identifierhttp://hdl.handle.net/11449/186181
dc.identifierWOS:000445195002133
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5367233
dc.languageeng
dc.publisherWiley-Blackwell
dc.relationPediatric Blood & Cancer
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.titleIdentification Somatic Variants FOXO3A and FOXK2 in Neuroblastoma Patients that May Affect Doxorubicin and Platin Chemoterapy
dc.typeOtros


Este ítem pertenece a la siguiente institución